DOCS — Dr Martens Cashflow Statement
0.000.00%
Last trade - 00:00- £711.43m
- £922.53m
- £764.90m
Annual cashflow statement for Dr Martens, fiscal year end - March 29th, GBP millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 30th | 2026 March 29th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 52 W | 52 W |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 181 | 129 | 69.2 | 4.5 | 23.8 |
| Depreciation | |||||
| Non-Cash Items | 50.1 | 58.5 | 60 | 39.1 | 38.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -83.8 | -168 | -33.6 | 75.9 | 7.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 184 | 77.3 | 168 | 196 | 143 |
| Capital Expenditures | -25 | -51.4 | -28.4 | -18.7 | -11.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0.8 | 2.9 | 3.4 | 3.7 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -25 | -50.6 | -25.5 | -15.3 | -8.2 |
| Financing Cash Flow Items | -10.8 | -12 | -34 | -42.4 | -27.2 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -47 | -99.5 | -186 | -134 | -108 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 114 | -70.5 | -46.4 | 44.8 | 24.4 |